Growth factor midkine is involved in the pathogenesis of diabetic nephropathy

Tomoki Kosugi, Yukio Yuzawa, Waichi Sato, Hanayo Kawai, Seiichi Matsuo, Yoshifumi Takei, Takashi Muramatsu, Kenji Kadomatsu

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Diabetic nephropathy is a life-threatening disease associated with diabetes mellitus. Longstanding hyperglycemia induces pathological reactions of glomerular mesangial cells, such as overproduction of extracellular matrix, which finally lead to nephropathy. However, the mechanisms underlying its pathogenesis have not been completely elucidated. Using the Streptozotocin- induced model of diabetes, we report that mice deficient in the growth factor midkine (Mdk-/-) exhibited strikingly milder nephropathy than Mdk +/+ mice, even though both mice showed similar extents of hyperglycemia after Streptozotocin injection. Midkine expression was induced in the glomerular mesangium of Mdk +/+ mice with diabetic nephropathy and in primary cultured mesangial cells exposed to high glucose. Mdk -/- mesangial cells exhibited reduced phosphorylation of protein kinase C and extracellular signal-regulated kinase as well as reduced production of transforming growth factor-β1 on high glucose loading. Addition of exogenous midkine restored extracellular signal-regulated kinase phosphorylation in Mdk -/- cells under high glucose conditions, whereas a midkine antisense oligodeoxynucleotide suppressed midkine in Mdk +/+ cells. Therefore, this study identifies midkine as a key molecule in diabetic nephropathy and suggests that midkine accelerates the intracellular signaling network evoked by hyperglycemia in nephropathy.

Original languageEnglish
Pages (from-to)9-19
Number of pages11
JournalAmerican Journal of Pathology
Volume168
Issue number1
DOIs
Publication statusPublished - 01-01-2006
Externally publishedYes

Fingerprint

Diabetic Nephropathies
Intercellular Signaling Peptides and Proteins
Mesangial Cells
Hyperglycemia
Extracellular Signal-Regulated MAP Kinases
Streptozocin
Glucose
Glomerular Mesangium
Phosphorylation
Oligodeoxyribonucleotides
Transforming Growth Factors
midkine
Protein Kinase C
Extracellular Matrix
Cultured Cells
Diabetes Mellitus
Injections

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Kosugi, Tomoki ; Yuzawa, Yukio ; Sato, Waichi ; Kawai, Hanayo ; Matsuo, Seiichi ; Takei, Yoshifumi ; Muramatsu, Takashi ; Kadomatsu, Kenji. / Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. In: American Journal of Pathology. 2006 ; Vol. 168, No. 1. pp. 9-19.
@article{fae7d3f85fae41478e4b08ec4b8ff5ba,
title = "Growth factor midkine is involved in the pathogenesis of diabetic nephropathy",
abstract = "Diabetic nephropathy is a life-threatening disease associated with diabetes mellitus. Longstanding hyperglycemia induces pathological reactions of glomerular mesangial cells, such as overproduction of extracellular matrix, which finally lead to nephropathy. However, the mechanisms underlying its pathogenesis have not been completely elucidated. Using the Streptozotocin- induced model of diabetes, we report that mice deficient in the growth factor midkine (Mdk-/-) exhibited strikingly milder nephropathy than Mdk +/+ mice, even though both mice showed similar extents of hyperglycemia after Streptozotocin injection. Midkine expression was induced in the glomerular mesangium of Mdk +/+ mice with diabetic nephropathy and in primary cultured mesangial cells exposed to high glucose. Mdk -/- mesangial cells exhibited reduced phosphorylation of protein kinase C and extracellular signal-regulated kinase as well as reduced production of transforming growth factor-β1 on high glucose loading. Addition of exogenous midkine restored extracellular signal-regulated kinase phosphorylation in Mdk -/- cells under high glucose conditions, whereas a midkine antisense oligodeoxynucleotide suppressed midkine in Mdk +/+ cells. Therefore, this study identifies midkine as a key molecule in diabetic nephropathy and suggests that midkine accelerates the intracellular signaling network evoked by hyperglycemia in nephropathy.",
author = "Tomoki Kosugi and Yukio Yuzawa and Waichi Sato and Hanayo Kawai and Seiichi Matsuo and Yoshifumi Takei and Takashi Muramatsu and Kenji Kadomatsu",
year = "2006",
month = "1",
day = "1",
doi = "10.2353/ajpath.2006.050488",
language = "English",
volume = "168",
pages = "9--19",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

Kosugi, T, Yuzawa, Y, Sato, W, Kawai, H, Matsuo, S, Takei, Y, Muramatsu, T & Kadomatsu, K 2006, 'Growth factor midkine is involved in the pathogenesis of diabetic nephropathy', American Journal of Pathology, vol. 168, no. 1, pp. 9-19. https://doi.org/10.2353/ajpath.2006.050488

Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. / Kosugi, Tomoki; Yuzawa, Yukio; Sato, Waichi; Kawai, Hanayo; Matsuo, Seiichi; Takei, Yoshifumi; Muramatsu, Takashi; Kadomatsu, Kenji.

In: American Journal of Pathology, Vol. 168, No. 1, 01.01.2006, p. 9-19.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Growth factor midkine is involved in the pathogenesis of diabetic nephropathy

AU - Kosugi, Tomoki

AU - Yuzawa, Yukio

AU - Sato, Waichi

AU - Kawai, Hanayo

AU - Matsuo, Seiichi

AU - Takei, Yoshifumi

AU - Muramatsu, Takashi

AU - Kadomatsu, Kenji

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Diabetic nephropathy is a life-threatening disease associated with diabetes mellitus. Longstanding hyperglycemia induces pathological reactions of glomerular mesangial cells, such as overproduction of extracellular matrix, which finally lead to nephropathy. However, the mechanisms underlying its pathogenesis have not been completely elucidated. Using the Streptozotocin- induced model of diabetes, we report that mice deficient in the growth factor midkine (Mdk-/-) exhibited strikingly milder nephropathy than Mdk +/+ mice, even though both mice showed similar extents of hyperglycemia after Streptozotocin injection. Midkine expression was induced in the glomerular mesangium of Mdk +/+ mice with diabetic nephropathy and in primary cultured mesangial cells exposed to high glucose. Mdk -/- mesangial cells exhibited reduced phosphorylation of protein kinase C and extracellular signal-regulated kinase as well as reduced production of transforming growth factor-β1 on high glucose loading. Addition of exogenous midkine restored extracellular signal-regulated kinase phosphorylation in Mdk -/- cells under high glucose conditions, whereas a midkine antisense oligodeoxynucleotide suppressed midkine in Mdk +/+ cells. Therefore, this study identifies midkine as a key molecule in diabetic nephropathy and suggests that midkine accelerates the intracellular signaling network evoked by hyperglycemia in nephropathy.

AB - Diabetic nephropathy is a life-threatening disease associated with diabetes mellitus. Longstanding hyperglycemia induces pathological reactions of glomerular mesangial cells, such as overproduction of extracellular matrix, which finally lead to nephropathy. However, the mechanisms underlying its pathogenesis have not been completely elucidated. Using the Streptozotocin- induced model of diabetes, we report that mice deficient in the growth factor midkine (Mdk-/-) exhibited strikingly milder nephropathy than Mdk +/+ mice, even though both mice showed similar extents of hyperglycemia after Streptozotocin injection. Midkine expression was induced in the glomerular mesangium of Mdk +/+ mice with diabetic nephropathy and in primary cultured mesangial cells exposed to high glucose. Mdk -/- mesangial cells exhibited reduced phosphorylation of protein kinase C and extracellular signal-regulated kinase as well as reduced production of transforming growth factor-β1 on high glucose loading. Addition of exogenous midkine restored extracellular signal-regulated kinase phosphorylation in Mdk -/- cells under high glucose conditions, whereas a midkine antisense oligodeoxynucleotide suppressed midkine in Mdk +/+ cells. Therefore, this study identifies midkine as a key molecule in diabetic nephropathy and suggests that midkine accelerates the intracellular signaling network evoked by hyperglycemia in nephropathy.

UR - http://www.scopus.com/inward/record.url?scp=30344443053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30344443053&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2006.050488

DO - 10.2353/ajpath.2006.050488

M3 - Article

C2 - 16400005

AN - SCOPUS:30344443053

VL - 168

SP - 9

EP - 19

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -